Literature DB >> 15881658

Angiotensin II stimulated transcription of cyclooxygenase II is regulated by a novel kinase cascade involving Pyk2, MEKK4 and annexin II.

Zachary E Derbyshire1, Ursula M Halfter, Ronald L Heimark, Terence H Sy, Richard R Vaillancourt.   

Abstract

Although it is known that MEKK4 regulates MKK6, and p38 MAP kinase, extracellular stimuli that activate the serine/threonine kinase, MEKK4, are unknown. The aim of this study was then to identify stimuli that regulate MEKK4. By using recombinant MEKK4, as bait to attract interacting proteins, the calcium binding protein, annexin II, was identified by mass spectrometry as interacting with MEKK4, suggesting that MEKK4 might be regulated by calcium. A calcium-dependent interaction between MEKK4 and annexin II was observed when MEKK4 was immunoprecipitated from rat aortic smooth muscle cells that were treated with angiotensin II. Additional studies using recombinant MEKK4 in a Far-Western immunoblot identified a protein of 120 kDa as interacting directly with MEKK4. Prior studies indicated that MEKK4 was phosphorylated on tyrosine in vivo, and in fact, Pyk2 interacts with MEKK4 in an angiotensin II dependent manner in rat aortic smooth muscle cells. Pyk2 phosphorylates MEKK4 in vitro and Pyk2-dependent phosphorylation further regulates MEKK4-dependent phosphorylation of MKK6. Finally, dominant-negative MEKK4 inhibits angiotensin II mediated transcription of a luciferase reporter construct containing the cyclooxygenase II promoter, demonstrating that MEKK4 functions in a calcium-dependent manner as a substrate for Pyk2 and regulates transcription of cyclooxygenase II.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15881658     DOI: 10.1007/s11010-005-5386-9

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  42 in total

1.  An enzyme-linked immunosorbent assay for the Raf/MEK1/MAPK signaling cascade.

Authors:  R Mallon; L R Feldberg; S C Kim; K Collins; D Wojciechowicz; I Hollander; E D Kovacs; C Kohler
Journal:  Anal Biochem       Date:  2001-07-01       Impact factor: 3.365

2.  Protein-tyrosine kinase Pyk2 mediates endothelin-induced p38 MAPK activation in glomerular mesangial cells.

Authors:  A Sorokin; P Kozlowski; L Graves; A Philip
Journal:  J Biol Chem       Date:  2001-02-26       Impact factor: 5.157

Review 3.  Organization and regulation of mitogen-activated protein kinase signaling pathways.

Authors:  T P Garrington; G L Johnson
Journal:  Curr Opin Cell Biol       Date:  1999-04       Impact factor: 8.382

4.  Activation of a novel calcium-dependent protein-tyrosine kinase. Correlation with c-Jun N-terminal kinase but not mitogen-activated protein kinase activation.

Authors:  H Yu; X Li; G S Marchetto; R Dy; D Hunter; B Calvo; T L Dawson; M Wilm; R J Anderegg; L M Graves; H S Earp
Journal:  J Biol Chem       Date:  1996-11-22       Impact factor: 5.157

5.  Mammalian mitogen-activated protein kinase pathways are regulated through formation of specific kinase-activator complexes.

Authors:  B W Zanke; E A Rubie; E Winnett; J Chan; S Randall; M Parsons; K Boudreau; M McInnis; M Yan; D J Templeton; J R Woodgett
Journal:  J Biol Chem       Date:  1996-11-22       Impact factor: 5.157

6.  Angiotensin II initiates tyrosine kinase Pyk2-dependent signalings leading to activation of Rac1-mediated c-Jun NH2-terminal kinase.

Authors:  S Murasawa; H Matsubara; Y Mori; H Masaki; Y Tsutsumi; Y Shibasaki; I Kitabayashi; Y Tanaka; S Fujiyama; Y Koyama; A Fujiyama; S Iba; T Iwasaka
Journal:  J Biol Chem       Date:  2000-09-01       Impact factor: 5.157

7.  The effect of angiotensin II on mitogen-activated protein kinase in human cardiomyocytes.

Authors:  C Wei; M G Cardarelli; S W Downing; J S McLaughlin
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2000-12       Impact factor: 1.636

8.  A family of stress-inducible GADD45-like proteins mediate activation of the stress-responsive MTK1/MEKK4 MAPKKK.

Authors:  M Takekawa; H Saito
Journal:  Cell       Date:  1998-11-13       Impact factor: 41.582

9.  Double tagging recombinant A1- and A2A-adenosine receptors with hexahistidine and the FLAG epitope. Development of an efficient generic protein purification procedure.

Authors:  A S Robeva; R Woodard; D R Luthin; H E Taylor; J Linden
Journal:  Biochem Pharmacol       Date:  1996-02-23       Impact factor: 5.858

10.  p36, the major cytoplasmic substrate of src tyrosine protein kinase, binds to its p11 regulatory subunit via a short amino-terminal amphiphatic helix.

Authors:  N Johnsson; G Marriott; K Weber
Journal:  EMBO J       Date:  1988-08       Impact factor: 11.598

View more
  10 in total

1.  MEKK4 signaling regulates filamin expression and neuronal migration.

Authors:  Matthew R Sarkisian; Christopher M Bartley; Hongbo Chi; Fumihiko Nakamura; Kazue Hashimoto-Torii; Masaaki Torii; Richard A Flavell; Pasko Rakic
Journal:  Neuron       Date:  2006-12-07       Impact factor: 17.173

Review 2.  Role of Annexin-II in GI cancers: interaction with gastrins/progastrins.

Authors:  Pomila Singh
Journal:  Cancer Lett       Date:  2006-12-22       Impact factor: 8.679

3.  Interferon-gamma-dependent tyrosine phosphorylation of MEKK4 via Pyk2 is regulated by annexin II and SHP2 in keratinocytes.

Authors:  Ursula M Halfter; Zachary E Derbyshire; Richard R Vaillancourt
Journal:  Biochem J       Date:  2005-05-15       Impact factor: 3.857

4.  Endothelium-derived contracting factors mediate the Ang II-induced endothelial dysfunction in the rat aorta: preventive effect of red wine polyphenols.

Authors:  Modou O Kane; Nelly Etienne-Selloum; Soccoro V F Madeira; Mamadou Sarr; Allison Walter; Stéphanie Dal-Ros; Christa Schott; Thierry Chataigneau; Valérie B Schini-Kerth
Journal:  Pflugers Arch       Date:  2009-11-29       Impact factor: 3.657

5.  HER2/HER3 regulates extracellular acidification and cell migration through MTK1 (MEKK4).

Authors:  James J Sollome; Elangovan Thavathiru; Todd D Camenisch; Richard R Vaillancourt
Journal:  Cell Signal       Date:  2013-09-12       Impact factor: 4.315

6.  Angiotensin II activates NF-κB through AT1A receptor recruitment of β-arrestin in cultured rat vascular smooth muscle cells.

Authors:  Thomas A Morinelli; Mi-Hye Lee; Ryan T Kendall; Louis M Luttrell; Linda P Walker; Michael E Ullian
Journal:  Am J Physiol Cell Physiol       Date:  2013-04-10       Impact factor: 4.249

7.  Excessive EP4 Signaling in Smooth Muscle Cells Induces Abdominal Aortic Aneurysm by Amplifying Inflammation.

Authors:  Taro Hiromi; Utako Yokoyama; Daisuke Kurotaki; Al Mamun; Ryo Ishiwata; Yasuhiro Ichikawa; Hiroshi Nishihara; Masanari Umemura; Takayuki Fujita; Shota Yasuda; Tomoyuki Minami; Motohiko Goda; Keiji Uchida; Shinichi Suzuki; Ichiro Takeuchi; Munetaka Masuda; Richard M Breyer; Tomohiko Tamura; Yoshihiro Ishikawa
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-04-23       Impact factor: 8.311

8.  HER2/HER3 regulates lactate secretion and expression of lactate receptor mRNA through the MAP3K4 associated protein GIT1.

Authors:  Alejandro E Garcia-Flores; James J Sollome; Elangovan Thavathiru; Joseph L Bower; Richard R Vaillancourt
Journal:  Sci Rep       Date:  2019-07-25       Impact factor: 4.379

9.  Loss of miR-936 leads to acquisition of androgen-independent metastatic phenotype in prostate cancer.

Authors:  Sarathkumar Edachery; Prakash Patil; Rajashekar Mohan; Bhuvanesh Aradhya; Jayaprakash Shetty; Shama Prasada Kabekkodu; Manas Kumar Santra; Sathisha Jayanna Gonchigar; Praveenkumar Shetty
Journal:  Sci Rep       Date:  2022-10-12       Impact factor: 4.996

10.  miR-625-3p regulates oxaliplatin resistance by targeting MAP2K6-p38 signalling in human colorectal adenocarcinoma cells.

Authors:  Mads Heilskov Rasmussen; Iben Lyskjær; Rosa Rakownikow Jersie-Christensen; Line Schmidt Tarpgaard; Bjarke Primdal-Bengtson; Morten Muhlig Nielsen; Jakob Skou Pedersen; Tine Plato Hansen; Flemming Hansen; Jesper Velgaard Olsen; Per Pfeiffer; Torben Falck Ørntoft; Claus Lindbjerg Andersen
Journal:  Nat Commun       Date:  2016-08-16       Impact factor: 14.919

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.